Pyxis Innovations Inc. Ex. 99

-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JxDObE9z6YRdbg4KPc0BpjlCe63uTnHEwB4buZ4EkgZ8MVVubiuHKSoVctd/UT82 vsJlIJpew8HoFDQS13zcHw== 0000905729-03-000292.txt : 20030801 0000905729-03-000292.hdr.sgml : 20030801 20030801143718 ACCESSION NUMBER: 0000905729-03-000292 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20030630 FILED AS OF DATE: 20030801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTERLEUKIN GENETICS INC CENTRAL INDEX KEY: 0001037649 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 943123681 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 135 BEAVER ST CITY: WATHAM STATE: MA ZIP: 02452 BUSINESS PHONE: 1-781-398-0700 MAIL ADDRESS: STREET 1: 135 BEAVER ST CITY: WATHAM STATE: MA ZIP: 02452 FORMER COMPANY: FORMER CONFORMED NAME: MEDICAL SCIENCE SYSTEMS INC DATE OF NAME CHANGE: 19971003 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ALTICOR HOLDINGS INC CENTRAL INDEX KEY: 0001257877 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23413 FILM NUMBER: 03817670 BUSINESS ADDRESS: STREET 1: 7575 FULTON ST EAST CITY: ADA STATE: MI ZIP: 49355-0001 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PYXIS INNOVATIONS INC CENTRAL INDEX KEY: 0001221575 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23413 FILM NUMBER: 03817671 BUSINESS ADDRESS: STREET 1: 7575 FULTON STREET EAST CITY: ADA STATE: MI ZIP: 49355-0001 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ALTICOR INC CENTRAL INDEX KEY: 0000941980 STATE OF INCORPORATION: MI FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23413 FILM NUMBER: 03817672 BUSINESS ADDRESS: STREET 1: 7575 FULTON ST CITY: ADA STATE: MI ZIP: 49355-7410 BUSINESS PHONE: 6167876928 MAIL ADDRESS: STREET 1: 7575 FULTON ST CITY: ADA STATE: MI ZIP: 49355-7410 FORMER NAME: FORMER CONFORMED NAME: AMWAY CORP DATE OF NAME CHANGE: 19990115 4 1 primary_doc.xml PRIMARY DOCUMENT X0201 4 2003-06-30 0 0001037649 INTERLEUKIN GENETICS INC ILGN 0001221575 PYXIS INNOVATIONS INC 7575 FULTON STREET EAST ADA MI 49355 0 0 1 0 0001257877 ALTICOR HOLDINGS INC 7575 FULTON STREET EAST ADA MI 49355 0 0 0 1 Parent Holding Company 0000941980 ALTICOR INC 7575 FULTON ST ADA MI 49355 0 0 0 1 Parent Holding Company Convertible Promissory Note 0.5 2003-06-30 4 P 0 1 595336 A 2003-06-30 1988-08-08 Common 1200986 1200986 D See Exhibit 99. Michael A. Mohr, Secretary, Pyxis Innovations Inc. 2003-07-22 EX-99 3 pyxisex99.htm EXHIBIT 99 Pyxis Innovations Inc. Ex. 99

EXHIBIT 99

Name and Address of Designated Reporting Person: Pyxis Innovations Inc. 7575 Ada, Michigan 49355-0001	Date of Event Requiring Statement: June 30, 2003	Issuer Name and Ticker or Trading Symbol: Interleukin Genetics, Inc. (ILGN)
Other Reporting Persons:
1. Alticor Inc. (2) *	* Except as provided in Footnote 2, all information reported above for the Designated Reporting Person is applicable to Alticor Inc.
2. Alticor Holdings Inc. (3) **	** Except as provided in Footnote 3, all information reported above for the Designated Reporting Person is applicable to Alticor Holdings Inc.

Footnote No. 1

On June 30, 2003, Pyxis acquired a promissory note from the Issuer with an original principal amount of $595,336. The principal amount of the note, plus accrued interest thereon, is convertible into the Issuer's common stock at any time at the option of Pyxis. This promissory note will be convertible into shares of common stock at a conversion price equal to two times the conversion price of the Series A Preferred Stock in effect (currently $.2486 per share, two times which would be $.4972 -- this number has been rounded to $.50 in Table II, Column 2 of this Form 4) at the time of conversion. Although the promissory note has a maturity date, there is no "expiration date" after which Pyxis may not exercise its right to convert the note into the Issuer's common stock; therefore, the Commission's place-marker date of "08/08/88" is used as the expiration date in Table II, Column 6 of this Form 4. As of July 22, 2003, the note would have been convertible into 1,200,986 shares of the Issuer's common stock.

Footnote No. 2

Pyxis Innovations Inc. is a wholly-owned subsidiary of Alticor Inc. Alticor Inc. does not beneficially own any shares of the Issuer directly. Alticor Inc.'s beneficial ownership designation results solely from its ownership of Pyxis Innovations Inc.

Name and Address of Designated Reporting Person:

Pyxis Innovations Inc.
7575 Ada, Michigan 49355-0001

Date of Event Requiring Statement:

June 30, 2003

Issuer Name and Ticker or Trading Symbol:

Interleukin Genetics, Inc. (ILGN)

Footnote No. 3

Alticor Inc. is a wholly-owned subsidiary of Alticor Holdings Inc. Alticor Holdings Inc. does not beneficially own any shares of the Issuer directly. Alticor Holdings Inc.'s beneficial ownership designation results solely from its ownership of Alticor Inc. and Alticor Inc.'s ownership of Pyxis Innovations Inc.

Signature of Non-Designated Reporting Persons:

Alticor Inc.		Alticor Holdings Inc.

/s/ Michael A. Mohr		/s/ Michael A. Mohr
** Signature of Reporting Person Michael A. Mohr, Vice President and Secretary		** Signature of Reporting Person Michael A. Mohr, Vice President and Secretary

-----END PRIVACY-ENHANCED MESSAGE-----